Paracrinology of endometrial neuropeptides: Corticotropin-releasing hormone and opioids

Citation
A. Gravanis et al., Paracrinology of endometrial neuropeptides: Corticotropin-releasing hormone and opioids, SEM REP END, 17(1), 1999, pp. 29-38
Citations number
87
Categorie Soggetti
Reproductive Medicine
Journal title
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY
ISSN journal
07348630 → ACNP
Volume
17
Issue
1
Year of publication
1999
Pages
29 - 38
Database
ISI
SICI code
0734-8630(1999)17:1<29:POENCH>2.0.ZU;2-G
Abstract
Human endometrium possesses remarkable secretory properties and the charact eristics of a neuroendocrine organ. Epithelial cells of human endometrium e xpress the corticotropin-releasing hormone (CRH) and opioid peptide precurs ors genes (i.e., proopiomelanocortin, proenkephalin, and prodynorphin) and their end products. Endometrial neuropeptides are under the control of ovar ian steroid hormones and locally produced prostanoids and cytokines. Additi onally, neuropeptides participate in local paracrine regulatory loops,facil itating communication between endometrial epithelial and stromal cells as w ell as the interaction between endometrial and myometrial cells. In view of the proinflammatory cytokine properties of CRH, we postulate that endometr ial CRH may participate in intrauterine inflammatory and vascular processes associated with stromal cell decidualization and blastocyst implantation. Additionally, given the myorelaxant actions of opioids these endometrial ne uropeptides may participate in the control of myometrial contractility.